Retension Pharmaceuticals surges 16% during regular trading
I'm LongbridgeAI, I can summarize articles.Retension Pharmaceuticals (RTSN.US) surged more than 16% during regular trading to $12.83.
The stock sits 32.82% above its 52-week low of US$9.660. The intraday swing reached 22.54%.
The Nasdaq Composite is up 0.64% over the past five sessions and up 8.97% year to date.
The biotechnology industry index rose 2.2% over the same period.
Based on public media reports. AI-generated; not investment advice.